DUBLIN, Ku ya 26 Kamena 2023– Raporo “Isoko ry’ibiyobyabwenge bya Peptide - Isesengura ry’isi yose n’akarere: Wibande ku bwoko bwa Peptide, Ibicuruzwa n’isesengura ry’akarere - Isesengura n’iteganyagihe, 2024-2040 ″.
Nyuma y’isoko rya mbere ry’imiti ya peptide yabujijwe bwa mbere, biteganijwe ko isoko ry’ibiyobyabwenge ryabujijwe ku isi riziyongera kuva mu 2024 kugeza mu 2040. Biteganijwe ko ingano y’isoko izagera kuri $ 60M muri 2024 na $ 17.38B muri 2040, hamwe na CAGR ya 38.94% hejuru igihe giteganijwe 2025-2040.
Biteganijwe ko isoko ry’ibiyobyabwenge byitwa peptide byabujijwe kwisi yose bizatera imbere cyane mugihe cyateganijwe kuva 2025 kugeza 2040, biterwa ahanini n’amasezerano y’iterambere rishya ryabujijwe imiyoboro ya peptide itagarukira gusa ku ntego zakira.Iterambere mu ikoranabuhanga ry’imiti, iterambere mu bucuruzi bw’imiti ivura peptide ya peptide mu myaka yashize, hamwe n’ibiciro bihendutse byagezweho n’ibi binyabuzima mu ndwara zitandukanye ni bimwe mu bintu byiyongera bigira uruhare mu kuzamuka guteganijwe mu gihe giteganijwe.
Isesengura ryingaruka zigihe gito nigihe kirekire rikorwa kubintu bigira ingaruka zikomeye ku isoko, aribyo abashoferi, imbogamizi n'amahirwe.Isuzuma ryigihe gito ryerekana igihe 2020-2025 naho isuzuma rirerire rireba igihe 2026-2040.
Iterambere ryingenzi ningamba zafashwe na bamwe mubagize uruhare runini muri iri soko bashyizwe mu isuzuma ry’ingaruka.Byongeye kandi, aya majyambere yingenzi arasuzumwa kugirango yumve amahirwe azaza yo guhuza ikoranabuhanga rigezweho kugirango agere kubisubizo byiza.Byongeye kandi, kwemeza no gutangiza ibigo n’ibigo by’ipatanti nabyo byitabwaho mugihe harebwa imbaraga zisoko ryisi yose kumiti ya peptide ibujijwe na peptide.
Ibisabwa hamwe nimbogamizi Ibikurikira nizo mpamvu zikenewe ku isoko rya Peptide Yishingikiriza ku Isi:
4 Incamake y'Isoko 4.1 Intangiriro 4.1.1 Imiterere nigishushanyo cya Peptide Yabujijwe 4.1.2 Ubwoko bwa Peptide Yabujijwe 4.2 Ubwihindurize bwa Peptide Yabujijwe 4.3 Gutezimbere Peptide Yabujijwe Ibiyobyabwenge 4.4 Ahantu hashobora kuvurwa 4.5 Urunigi rw’agaciro - Abafatanyabikorwa b’ingenzi 4.6 Inzira z’inganda (mu karere) ).
5 Ibyiza bya peptide yabujijwe guhinduka 5.1 Ibyiza bya peptide yabujijwe guhinduka 5.2 Synthesis ya peptide yabujijwe 5.2.1 Gutera imiti ya peptide hamwe nikiraro 5.2.2 Gutera imiti ya peptide kuri scafolds (CLIPS) 5.2.3 Guhuza peptide 5.2.4 Ihuriro rya peptide kuvumbura (5.2.5. Hitamo Sisitemu
6 Ibyerekeye Inganda 6.1 Incamake 6.2 Ibibazo hamwe ninzira zemewe zemewe na peptide yagabanijwe 6.3 Ibipimo ngengamikorere kuri peptide yabujijwe 6.4 Ibisabwa n’ubuyobozi muri Amerika 6.4.1 Uruhushya rwo kugerageza ivuriro 6.4.2 Uruhushya rwo kwamamaza muri Amerika 6.4.3 Amabwiriza yo gutanga FDA muri Amerika NDA 6.4.4 Nyuma yo gutanga uruhushya amategeko 6.5 Ibisabwa n’ibihugu by’i Burayi 6.5.1 Gahunda yo gusaba uruhushya rwa EMA 6.5.2 Uburyo bukomatanyije 6.5.3 Uburyo bwo kwegereza ubuyobozi abaturage 6.5.4 Uburyo bwo kumenyekanisha hagati yabo 6.5.5 Inzira z’igihugu 6.6 Ibisabwa n’amategeko muri Aziya -Akarere k’amahoro 6.6.1 Ibisabwa n'amategeko hamwe nu miterere mu Buyapani 6.7 Ibihe byo kwishyura 6.7.1 Ibihe byo kwishyura indwara ya Autoimmune 6.7.2 Ibihe byo kwishyura kanseri 6.7.3.
7 Imikorere y'Isoko 7.1 Isesengura ry'ingaruka 7.2 Ibintu by'isoko 7.2.1 Kongera umubano uhuza hamwe no gufata selile 7.2.2 Gutezimbere uburyo buke bwa sintetike 7.2.3 Imipaka ya peptide isanzwe 7.2.4 Kwiyongera mubuterankunga bwa leta n'abikorera 7.2.4.1 Inkunga yibigo byigenga 7.24.1 .4.2 Inkunga yatanzwe n’ibigo byashyizwe ku rutonde 7.2.4.3 Inkunga yatanzwe n’ibigo bya Leta 7.3 Inzitizi z’isoko 7.3.1 Kongera amarushanwa y’ibinyabuzima 7.3.2 Ingaruka z’ingaruka z’ubudahangarwa hamwe n’umutungo udasanzwe wa ADME 7.4 Amahirwe y’isoko 7.4.1 Peptide nkeya mu kuvumbura ibiyobyabwenge 7.4.2 Porogaramu zitandukanye sisitemu yo kuvura no kuvura kanseri
8 Imiterere ihiganwa 8.1 Incamake yimiterere yapiganwa 8.1.1 Iterambere ryingenzi 8.1.2 Ibikorwa bigenga amategeko n amategeko 8.1.3 Guhuriza hamwe no kugura 8.1.4 Ibikorwa byo gukorana 8.1.5 Ibikorwa byubukungu 8.1.6 Iterambere ryamavuriro
9 Isoko ryisi yose yo kubuza imiti ya peptide (ukurikije icyerekezo), miriyoni USD, 2024–2040 9.1 Igishushanyo mbonera cyamavuriro yo kubuza imiti ya peptide 9.1.1 Ubuvuzi bwicyiciro cya II II) 9.1.2.3 Amakuru yingirakamaro, umutekano, no kwihanganira amakuru (Icyiciro 1) 9.1 .2.4. 4 amakuru yo kwihanganira (Icyiciro cya IIa) 9.1.6 Ibiyobyabwenge bishoboka Icyiciro cya III 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Incamake y'ibicuruzwa 9.1.7.2 Igishushanyo mbonera cyo kwiga (Icyiciro cya III) 9.1.7.3 Amakuru yingirakamaro, umutekano no kwihanganira (Icyiciro cya III) 9.1.7.4 Umwirondoro wa Pharmacokinetic na pharmacodynamic ya Zilucoplan (Icyiciro cya I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Incamake yibicuruzwa 9.1.8.2 Igishushanyo mbonera cyo kwiga (Icyiciro cya III) 9.1.8.3 Amakuru yingirakamaro, umutekano no kwihanganira (Icyiciro cya II) 9.2 Isesengura ryisesengura iterambere ryiterambere ryisoko ryisi yose kumiti ya peptide yabujijwe, miliyoni USD, 2024-2040 intsinzi 9.2.2.2 Igiciro cyumusaruro wa API (CDMO)
Isoko ryisi yose yibiyobyabwenge bifite peptide nkeya (kubwoko bwa peptide), miliyoni US $ US, 2024–2040 bihuza peptide (DRP))
11 Isoko ryisi yose kumiti ya peptide yabujijwe (kubicuruzwa bishobora), miriyoni USD, 2024–2040 (RA101495) 11.1.2.1 Umusaruro wa API (murugo) 11.1.2.2. .3.1 Umusaruro wa API (Outsourcing) Igiciro 11.1.4 PN-94311.1.4.1 Umusaruro wa API (Outsourcing) 11.1.4.2 API Ibisabwa 2024-2040
Igihe cyo kohereza: Jul-06-2023